Risk factors for placenta previa among pregnant women of Kyiv, Ukraine: a retrospective cohort study





women, placentation, placenta previa, cesarean section, curettage, instrumental abortion, assisted reproductive technologies, obstetric hemorrhage, preterm delivery


Placenta previa is a significant obstetric problem with elevated morbidity and mortality rates for both mother and fetus. The risks associated with placenta previa underscore the necessity for comprehensive treatment and timely intervention to mitigate adverse outcomes.

Purpose - to conduct a retrospective analysis of the impact of obstetric-gynecological factors on the prediction of placenta previa occurrence and its influence on perinatal outcomes.

Materials and methods. A retrospective cohort study was conducted on cases of placenta previa between 2018 and 2022. The study included 22491 deliveries, of which 65 (0.29%) cases were registered as placenta previa. Data from delivery records of 374 patients without placenta previa were used for comparison. The following variables were evaluated for all patients: maternal age, characteristics of the menstrual cycle, gravidity, parity, history of cesarean sections, gestational age at delivery, method of delivery, blood loss during delivery, length of postpartum hospitalization, birth weight, gender of the newborn, Apgar scores at 1 and 5 minutes. Gynecological intervention histories, including curettage/hysteroscopy, laparoscopy, and cervical treatment, as well as obstetric pathologies, such as cesarean section, ectopic pregnancy, instrumental abortions, missed pregnancies, and assisted reproductive technologies in the last pregnancy, were examined.

Results. Multifactorial analysis revealed four significant risk factors. The risk of placenta previa was found to increase with advanced maternal age (p<0.001), OR=1.14 (95% CI 1.07-1.20), and the presence of previous cesarean sections (p<0.001), OR=5.51 (95% CI 2.73-11.1), while a history of previous deliveries reduced the risk (p<0.001), OR=0.24 (95% CI 0.15-0.40). Instrumental abortions increased the risk of placenta previa (p=0.001), OR=2.14 (95% CI 1.20-3.81). Newborns in the placenta previa group had lower Apgar scores at 1 and 5 minutes and lower birth weight.

Conclusions. The obtained results emphasize the importance of considering risk factors in assessing placenta previa occurrence during antenatal monitoring and can contribute to improving obstetric and perinatal care for women. However, the morphological and functional basis of placenta previa remains unknown and requires further study.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of participating institution.

No conflict of interests was declared by the authors.

Author Biographies

V.O. Berestovyi, Bogomolets National Medical University, Kyiv

Kyiv City Maternity Hospital No.5, Ukraine

N.V. Gerevich, Bogomolets National Medical University, Kyiv

Kyiv City Maternity Hospital No.5

D.O. Govsieiev, Bogomolets National Medical University, Kyiv

Kyiv City Maternity Hospital No.5, Ukraine


Abduljabbar HS, Bahkali NM, Al-Basri SF, Al Hachim E, Shoudary IH, Dause WR et al. (2016). Placenta previa: A 13 years experience at a tertiary care center in Western Saudi Arabia. Saudi Medical Journal. 37 (7): 762. https://doi.org/10.15537/smj.2016.7.13259; PMid:27381536 PMCid:PMC5018640

Adnan WFW, Shamsudin F, Zon EM. (2021). Uterine torsion in patient with major placenta previa. European Journal of Obstetrics and Gynecology and Reproductive Biology. 258: 467-469. https://doi.org/10.1016/j.ejogrb.2020.12.007; PMid:33483151

Ahmed SR, Aitallah A, Abdelghafar HM, Alsammani MA. (2015). Major placenta previa: rate, maternal and neonatal outcomes experience at a tertiary maternity hospital, sohag, Egypt: a prospective study. Journal of clinical and diagnostic research: JCDR. 9 (11): QC17. https://doi.org/10.7860/JCDR/2014/14930.6831; PMid:26674539 PMCid:PMC4668479

Anderson-Bagga FM, Sze A. (2023, Jun). Placenta Previa. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. URL: https://www.ncbi.nlm.nih.gov/books/NBK539818/.

Balayla J, Desilets J, Shrem G. (2019). Placenta previa and the risk of intrauterine growth restriction (IUGR): a systematic review and meta-analysis. Journal of perinatal medicine. 47 (6): 577-584. https://doi.org/10.1515/jpm-2019-0116; PMid:31301678

Baumfeld Y, Herskovitz R, Niv ZB, Mastrolia SA, Weintraub AY. (2017). Placenta associated pregnancy complications in pregnancies complicated with placenta previa. Taiwanese Journal of Obstetrics and Gynecology. 56 (3): 331-335. https://doi.org/10.1016/j.tjog.2017.04.012; PMid:28600043

Crane JM, Van den Hof MC, Dodds L, Armson BA, Liston R. (1999). Neonatal outcomes with placenta previa. Obstetrics & Gynecology. 93 (4): 541-544. https://doi.org/10.1097/00006250-199904000-00014; PMid:10214830

Fan D, Wu S, Liu L, Xia Q, Wang W, Guo X et al. (2017). Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Scientific reports. 7 (1): 1-9. https://doi.org/10.1038/srep40320; PMid:28067303 PMCid:PMC5220286

Jain V, Bos H, Bujold E. (2020). Guideline No. 402: diagnosis and management of placenta previa. Journal of Obstetrics and Gynaecology Canada. 42 (7): 906-917. e901. https://doi.org/10.1016/j.jogc.2019.07.019; PMid:32591150

Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Collins S et al. (2018). Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. Bjog. 126 (1): e1-e48. https://doi.org/10.1111/1471-0528.15306; PMid:30260097

Kollmann M, Gaulhofer J, Lang U, Klaritsch P. (2016). Placenta praevia: incidence, risk factors and outcome. The Journal of Maternal-Fetal & Neonatal Medicine. 29 (9): 1395-1398. https://doi.org/10.3109/14767058.2015.1049152; PMid:26043298

Makarenko M, Govsieiev D, Martynova L, Berestovoy V, Vorona R. (2016). Assisted reproductive technology and intrauterine pathology as the risk factors of placenta praevia. Health of woman. 10 (116): 140-142. https://doi.org/10.15574/HW.2016.116.140

Onwere C, Gurol-Urganci I, Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH. (2011). Maternal morbidity associated with placenta praevia among women who had elective caesarean section. European Journal of Obstetrics & Gynecology and Reproductive Biology. 159 (1): 62-66. https://doi.org/10.1016/j.ejogrb.2011.07.008; PMid:21835537

Petersen SH, Bergh C, Gissler M, Åsvold BO, Romundstad LB, Tiitinen A et al. (2020). Time trends in placenta-mediated pregnancy complications after assisted reproductive technology in the Nordic countries. American journal of obstetrics and gynecology. 223 (2): 226. e221-226. e219. https://doi.org/10.1016/j.ajog.2020.02.030; PMid:32109461

Qin JB, Wang H, Sheng X, Xie Q, Gao S. (2016). Assisted reproductive technology and risk of adverse obstetric outcomes in dichorionic twin pregnancies: a systematic review and meta-analysis. Fertility and sterility. 105 (5): 1180-1192. https://doi.org/10.1016/j.fertnstert.2015.12.131; PMid:26801066

Rao J, Fan D, Zhou Z, Luo X, Ma H, Wan Y et al. (2021, Jul 6). Maternal and neonatal outcomes of placenta Previa with and without coverage of a uterine scar: a retrospective cohort study in a tertiary hospital. International Journal of Women's Health. 13: 671-681. https://doi.org/10.2147/IJWH.S310097; PMid:34262357 PMCid:PMC8273910

Sakai Y, Ono M, Iizuka T, Kagami K, Masumoto S, Nakayama M et al. (2019). Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum. Journal of Obstetrics and Gynaecology Research. 45 (12): 2394-2399. https://doi.org/10.1111/jog.14111; PMid:31456311

Schneiderman M, Balayla J. (2013). A comparative study of neonatal outcomes in placenta previa versus cesarean for other indication at term. The Journal of Maternal-Fetal & Neonatal Medicine. 26 (11): 1121-1127. https://doi.org/10.3109/14767058.2013.770465; PMid:23356588

Senkoro EE, Mwanamsangu AH, Chuwa FS, Msuya SE, Mnali OP, Brown BG et al. (2017). Frequency, risk factors, and adverse fetomaternal outcomes of placenta previa in Northern Tanzania. Journal of pregnancy. 2017: 5936309. https://doi.org/10.1155/2017/5936309; PMid:28321338 PMCid:PMC5339534

Sheiner E, Shoham-Vardi I, Hallak M, Hershkowitz R, Katz M, Mazor M. (2001). Placenta previa: obstetric risk factors and pregnancy outcome. Journal of Maternal-Fetal Medicine. 10 (6): 414-419. https://doi.org/10.1080/jmf.10.6.414.419

Silver RM, Branch DW. (2018). Placenta accreta spectrum. New England Journal of Medicine. 378 (16): 1529-1536. https://doi.org/10.1056/NEJMcp1709324; PMid:29669225

Tuzovic L, Djelmis J, Ilijic M. (2003). Obstetric risk factors associated with placenta previa development: case-control study. Croat Med J. 44 (6): 728-733.

Vahanian SA, Lavery JA, Ananth CV, Vintzileos A. (2015). Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. American journal of obstetrics and gynecology. 213 (4): S78-S90. https://doi.org/10.1016/j.ajog.2015.05.058; PMid:26428506

Wortman AC, Alexander JM. (2013). Placenta accreta, increta, and percreta. Obstetrics and Gynecology Clinics. 40 (1): 137-154. https://doi.org/10.1016/j.ogc.2012.12.002; PMid:23466142

Zhou C, Zhao Y, Li Y. (2022). Clinical Analysis of Factors Influencing the Development of Placenta Praevia and Perinatal Outcomes in First-Time Pregnant Patients. Frontiers in Surgery. 9: 862655. https://doi.org/10.3389/fsurg.2022.862655; PMid:35392051 PMCid:PMC8980226






Original articles